Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.
BACKGROUND
Patients with haematological malignancy admitted to intensive care have a high mortality. Adverse prognostic factors include the number of organ failures, invasive mechanical ventilation and previous bone marrow transplantation. Severity-of-illness scores may underestimate the mortality of critically ill patients with haematological malignancy. This study investigates the relationship between admission characteristics and outcome in patients with haematological malignancies admitted to intensive care units (ICUs) in England, Wales and Northern Ireland, and assesses the performance of three severity-of-illness scores in this population.


METHODS
A secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme Database was conducted on admissions to 178 adult, general ICUs in England, Wales and Northern Ireland between 1995 and 2007. Multivariate logistic regression analysis was used to identify factors associated with hospital mortality. The Acute Physiology and Chronic Health Evaluation (APACHE) II score, Simplified Acute Physiology Score (SAPS) II and ICNARC score were evaluated for discrimination (the ability to distinguish survivors from nonsurvivors); and the APACHE II, SAPS II and ICNARC mortality probabilities were evaluated for calibration (the accuracy of the estimated probability of survival).


RESULTS
There were 7,689 eligible admissions. ICU mortality was 43.1% (3,312 deaths) and acute hospital mortality was 59.2% (4,239 deaths). ICU and hospital mortality increased with the number of organ failures on admission. Admission factors associated with an increased risk of death were bone marrow transplant, Hodgkin's lymphoma, severe sepsis, age, length of hospital stay prior to intensive care admission, tachycardia, low systolic blood pressure, tachypnoea, low Glasgow Coma Score, sedation, PaO2:FiO2, acidaemia, alkalaemia, oliguria, hyponatraemia, hypernatraemia, low haematocrit, and uraemia. The ICNARC model had the best discrimination of the three scores analysed, as assessed by the area under the receiver operating characteristic curve of 0.78, but all scores were poorly calibrated. APACHE II had the highest accuracy at predicting hospital mortality, with a standardised mortality ratio of 1.01. SAPS II and the ICNARC score both underestimated hospital mortality.


CONCLUSIONS
Increased hospital mortality is associated with the length of hospital stay prior to ICU admission and with severe sepsis, suggesting that, if appropriate, such patients should be treated aggressively with early ICU admission. A low haematocrit was associated with higher mortality and this relationship requires further investigation. The severity-of-illness scores assessed in this study had reasonable discriminative power, but none showed good calibration.
Hampshire
Peter A
PA
Royal Liverpool University Hospital, Prescot Street, Liverpool, L7 8XP, UK. drphampshire@hotmail.com
Welch
Catherine A
CA
McCrossan
Lawrence A
LA
Francis
Katharine
K
Harrison
David A
DA
D000328:Adult; D000368:Aged; D003422:Critical Care; D005260:Female; D019337:Hematologic Neoplasms / Q000401:mortality*; D006751:Hospital Information Systems; D017052:Hospital Mortality; D006757:Hospital Units; D006801:Humans; D008297:Male; D008875:Middle Aged; D010343:Patient Admission; D012720:Severity of Illness Index; D006113:United Kingdom
N Engl J Med. 2001 Nov 8;345(19):1368-77
11794169
Blood. 2001 Dec 1;98(12):3234-40
11719359
Crit Care. 2004 Apr;8(2):R99-111
15025784
Acta Anaesthesiol Scand. 2003 Mar;47(3):301-6
12648196
Chest. 1988 Jul;94(1):99-102
3383663
Eur J Cancer. 1997 Jun;33(7):1031-7
9376183
J Clin Oncol. 1999 Mar;17(3):991-7
10071294
Br J Anaesth. 2001 Oct;87(4):543-8
11878722
Br J Cancer. 1991 Nov;64(5):938-42
1931620
Intensive Care Med. 1998 Dec;24(12):1283-8
9885881
Intensive Care Med. 1990;16(5):291-7
2212252
Chest. 2004 Nov;126(5):1604-11
15539734
Crit Care Med. 2003 Sep;31(9):2332-8
14501964
Chest. 1993 Aug;104(2):527-31
8339643
J Clin Oncol. 1998 Feb;16(2):761-70
9469368
Intensive Care Med. 2002 Dec;28(12):1775-80
12447522
Support Care Cancer. 2005 May;13(5):332-8
15864663
Intensive Care Med. 2006 Oct;32(10):1560-8
16896863
Chest. 2002 Jan;121(1):185-8
11796449
Eur J Haematol. 2005 Jun;74(6):511-6
15876255
Eur Respir J. 1998 Jul;12(1):116-22
9701425
Chest. 2004 Oct;126(4):1299-306
15486396
Crit Care Med. 1985 Oct;13(10):818-29
3928249
Swiss Med Wkly. 2001 Dec 22;131(47-48):681-6
11875752
Intensive Care Med. 2002 Sep;28(9):1294-300
12209280
Crit Care Med. 2006 May;34(5):1378-88
16557153
Support Care Cancer. 2003 Nov;11(11):686-95
12905057
Anaesthesia. 2005 Apr;60(4):340-7
15766336
Crit Care Med. 2002 Oct;30(10):2260-70
12394954
Radiology. 1982 Apr;143(1):29-36
7063747
Crit Care Med. 2008 Mar;36(3):690-6
18431262
Intensive Care Med. 1999 Dec;25(12):1395-401
10660847
Crit Care Med. 2007 Apr;35(4):1091-8
17334248
Intensive Care Med. 2003 Oct;29(10):1688-95
13680115
Am J Respir Crit Care Med. 1998 Sep;158(3):876-84
9731020
Ann Intern Med. 1996 Oct 15;125(8):625-33
8849146
Br Med J (Clin Res Ed). 1988 Apr 9;296(6628):1025-9
3130123
Chest. 1999 Oct;116(4):1012-8
10531167
J Clin Oncol. 2006 Feb 1;24(4):643-9
16380411
Crit Care Med. 2003 Jan;31(1):104-12
12545002
JAMA. 1993 Dec 22-29;270(24):2957-63
8254858
N Engl J Med. 2001 Feb 15;344(7):481-7
11172189
N Engl J Med. 1999 Feb 11;340(6):409-17
9971864
Crit Care Med. 2006 May;34(5):1297-310
16540951
Br J Haematol. 2007 Feb;136(3):448-50
17156405